tiprankstipranks
Altimmune (ALT)
NASDAQ:ALT

Compare Altimmune (ALT) vs. Competitors

3,632 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Altimmune
$3.37
$438.34M
-8.17%
5 Buy
1 Hold
0 Sell
Strong Buy
Tvardi Therapeutics
$3.05
$28.61M
-1.75
-79.04%
4 Buy
3 Hold
0 Sell
Moderate Buy
Diamedica Therapeutics
$6.19
$333.53M
-11.41
83.14%
4 Buy
0 Hold
0 Sell
Strong Buy
Alpha Tau Medical Ltd
$6.84
$633.67M
-9.36
189.16%
2 Buy
1 Hold
0 Sell
Moderate Buy
enGene Holdings
$7.31
$489.69M
-5.39
77.43%
6 Buy
1 Hold
0 Sell
Strong Buy
Lexeo Therapeutics, Inc.
$6.31
$477.12M
-53.29
253.85%
5 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ALT
Altimmune
3.37
-0.86
-20.33%
TVRD
Tvardi Therapeutics
3.05
-11.65
-79.25%
DMAC
Diamedica Therapeutics
6.19
2.49
67.30%
DRTS
Alpha Tau Medical Ltd
7.20
4.66
183.46%
ENGN
enGene Holdings
7.31
3.28
81.39%
LXEO
Lexeo Therapeutics, Inc.
6.44
4.08
172.88%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts